CMMB logo

Chemomab Therapeutics Ltd. (CMMB)

Profile

Full Name

Chemomab Therapeutics Ltd.

Ticker

NASDAQ: CMMB

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Israel

IPO

February 12, 2019

Indexes

Not included

Website

https://www.chemomab.com

Employees

20

Key Details

Price

$3.03(-0.59%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$3.13(-52.57% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $3.03
    CMMB price is $3.03

    30-Day Relative Volume

    0.22
    CMMB 30-day relative volume is 0.22

    Price Performance

    Price Most recent change

    -0.59%
    CMMB price was down -0.59% on Sep 12, 2025

    Price YTD change

    -58.12%
    CMMB price is down -58.12% since January 1st

    Price 1-year change

    -62.1%
    CMMB price is down -62.1% year-on-year

    Price 3-year change

    -77.97%
    CMMB price is down -77.97% over the past 3 years

    Price Range

    Price All-time high

    $736.00
    CMMB price is currently -99.59% below its historical high of $736.00

    Price 3-year low

    $1.68
    CMMB price is currently +80.48% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $15.74M
    CMMB market capitalization is $15.74 million

    Market cap 3-year change

    -59.98%
    CMMB market capitalization is down -59.98% over the past 3 years

    Market cap All-time high

    $2.35B
    CMMB market capitalization is currently -99.33% below its historical high of $2.35 billion

    Market cap sector rank

    20.27%
    CMMB market capitalization is higher than 20.27% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +12.19%
    CMMB shares outstanding is up +12.19% year-on-year

    Shares Outstanding 3-Year Change

    +81.64%
    CMMB shares outstanding is up +81.64% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.68
    CMMB beta is 0.68

    200-day SMA

    $5.56
    CMMB price is currently -45.42% below its 200-day simple moving average

    50-day SMA

    $3.90
    CMMB price is currently -22.22% below its 50-day simple moving average

    RSI

    26.67
    CMMB 14-day relative strength index is 26.67

    Volume

    0.22
    CMMB 30-day relative volume is 0.22

    ATR

    $0.21
    CMMB average true range is $0.21

    10-day Historical Volatility

    44.68%
    CMMB 10-day historical volatility is 44.68%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    CMMB annual revenue is $0.00

    Revenue Analysts estimate

    -
    CMMB annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    CMMB annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.75%
    CMMB annual revenue is higher than 28.75% of companies in Healthcare sector

    EPS

    EPS

    -$3.13
    CMMB annual earnings per share is -$3.13

    EPS Analysts estimate

    -$0.08
    CMMB annual earnings per share is currently +3818.50% higher than the consensus analysts' forecast

    EPS 1-year change

    -52.57%
    CMMB annual earnings per share is down -52.57% year-on-year

    EPS Sector rank

    27.69%
    CMMB annual earnings per share is higher than 27.69% of companies in Healthcare sector

    Profit

    Gross profit

    -$53.30K
    CMMB annual gross profit is -$53.30 thousand

    Gross margin

    -
    CMMB annual gross profit margin value is unknown

    Operating profit

    -$14.81M
    CMMB annual operating income is -$14.81 million

    Operating margin

    -
    CMMB annual operating profit margin value is unknown

    Net income

    -$14.01M
    CMMB annual net profit is -$14.01 million

    Net margin

    -
    CMMB annual net profit margin value is unknown

    Expenses

    Total expenses

    $14.01M
    CMMB annual total expenses is $14.01 million

    Operating expenses

    $14.76M
    CMMB annual total operating expenses is $14.76 million

    Cost of goods sold

    $53.30K
    CMMB annual cost of goods sold is $53.30 thousand

    Selling, general & administrative expenses

    $0.00
    CMMB annual SGA is $0.00

    Depreciation and amortization

    $53.30K
    CMMB annual depreciation & amortization is $53.30 thousand

    Interest expense

    $0.00
    CMMB annual interest expense is $0.00

    Income tax

    $0.00
    CMMB annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$14.81M
    CMMB annual earnings before interest & taxes is -$14.81 million

    EBITDA

    -$14.76M
    CMMB annual EBITDA is -$14.76 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $16.96M
    CMMB annual total assets is $16.96 million

    Non current assets

    $924.00K
    CMMB annual long term assets is $924.00 thousand

    Current assets

    $16.04M
    CMMB annual total current assets is $16.04 million

    Cash and cash equivalents

    $14.34M
    CMMB annual cash & cash equivalents is $14.34 million

    Accounts receivable

    -
    CMMB annual accounts receivable value is unknown

    Inventory

    $0.00
    CMMB annual inventory is $0.00

    Liabilities

    Total liabilities

    $3.43M
    CMMB annual total liabilities is $3.43 million

    Long term liabilities

    $209.00K
    CMMB annual total long term liabilities is $209.00 thousand

    Current liabilities

    $3.22M
    CMMB annual total current liabilities is $3.22 million

    Accounts payable

    $666.00K
    CMMB annual accounts payable is $666.00 thousand

    Debt

    Total debt

    $324.00K
    CMMB annual total debt is $324.00 thousand

    Total debt 1-year change

    -17.35%
    CMMB annual total debt is down -17.35% year-on-year

    Long term debt

    $209.00K
    CMMB annual long term debt is $209.00 thousand

    Short term debt

    $115.00K
    CMMB annual short term debt is $115.00 thousand

    Equity & Capital

    Shareholders equity

    $13.54M
    CMMB annual stockholders equity is $13.54 million

    Book value

    $13.54M
    CMMB annual book value is $13.54 million

    Retained earnings

    -$102.62M
    CMMB annual retained earnings is -$102.62 million

    Working capital

    $12.82M
    CMMB annual working capital is $12.82 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$15.46M
    CMMB annual cash flow from operations is -$15.46 million

    Cash from operations 1-year change

    +34.36%
    CMMB annual cash flow from operations is up +34.36% year-on-year

    Cash from investing

    $2.31M
    CMMB annual cash flow from investing activities is $2.31 million

    Cash from investing 1-year change

    -85.43%
    CMMB annual cash flow from investing activities is down -85.43% year-on-year

    Cash from financing

    $9.91M
    CMMB annual cash flow from financing activities is $9.91 million

    Cash from financing 1-year change

    +183.69%
    CMMB annual cash flow from financing activities is up +183.69% year-on-year

    CAPEX

    CAPEX

    $0.00
    CMMB annual capital expenditures is $0.00

    CAPEX 1-year change

    -100%
    CMMB annual capital expenditures is down -100% year-on-year

    Free Cash Flow

    Free cash flow

    -$15.46M
    CMMB annual free cash flow is -$15.46 million

    Free cash flow 1-year change

    +34.37%
    CMMB annual free cash flow is up +34.37% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    CMMB annual gross profit margin value is unknown

    Operating margin

    -
    CMMB annual operating profit margin value is unknown

    Net margin

    -
    CMMB annual net profit margin value is unknown

    ROA & ROE

    ROA

    -71.64%
    CMMB annual return on assets is -71.64%

    ROE

    -91.77%
    CMMB annual return on equity is -91.77%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CMMB price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CMMB price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.62
    CMMB price to book ratio is 1.62

    PB ratio Sector rank

    47.55%
    CMMB price to book ratio is higher than 47.55% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    CMMB price to sales ratio value is unknown

    PS ratio Sector rank

    -
    CMMB price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $6.23M
    CMMB enterprise value is $6.23 million

    Enterprise value Sector rank

    18.7%
    CMMB enterprise value is higher than 18.7% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.66
    CMMB EV/EBITDA is -0.66

    EV/EBITDA Sector rank

    50.94%
    CMMB EV/EBITDA is higher than 50.94% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.98
    CMMB annual current ratio is 4.98

    Quick ratio

    4.98
    CMMB annual quick ratio is 4.98

    Leverage

    Debt to equity

    0.02
    CMMB annual debt to equity ratio is 0.02

    Interest coverage ratio

    -
    CMMB annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    CMMB piotroski f-score value is unknown

    Altman Z-Score

    -7.69
    CMMB altman z-score is -7.69

    Analyst ratings

    Recent major analysts updates

    Aug 27, 25 Oppenheimer
    Outperform
    May 16, 25 Oppenheimer
    Outperform
    Feb 20, 25 Maxim Group
    Buy
    Nov 15, 24 Oppenheimer
    Outperform
    May 13, 24 Maxim Group
    Buy
    May 6, 24 Oppenheimer
    Outperform
    Mar 8, 24 Oppenheimer
    Perform
    Oct 6, 23 Roth MKM
    Buy
    Jun 7, 23 Oppenheimer
    Perform
    Apr 18, 23 Oppenheimer
    Outperform

    Institutional Ownership

    Screeners with CMMB included

    Growing Shares Outstanding
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    Ex Dividend dates calendar
    • What is the ticker symbol for Chemomab Therapeutics Ltd.?
    • Does Chemomab Therapeutics Ltd. pay dividends?
    • What sector is Chemomab Therapeutics Ltd. in?
    • What industry is Chemomab Therapeutics Ltd. in?
    • What country is Chemomab Therapeutics Ltd. based in?
    • When did Chemomab Therapeutics Ltd. go public?
    • Is Chemomab Therapeutics Ltd. in the S&P 500?
    • Is Chemomab Therapeutics Ltd. in the NASDAQ 100?
    • Is Chemomab Therapeutics Ltd. in the Dow Jones?
    • When was Chemomab Therapeutics Ltd.'s last earnings report?
    • When does Chemomab Therapeutics Ltd. report earnings?

    What is the ticker symbol for Chemomab Therapeutics Ltd.?

    The ticker symbol for Chemomab Therapeutics Ltd. is NASDAQ:CMMB

    Does Chemomab Therapeutics Ltd. pay dividends?

    No, Chemomab Therapeutics Ltd. does not pay dividends

    What sector is Chemomab Therapeutics Ltd. in?

    Chemomab Therapeutics Ltd. is in the Healthcare sector

    What industry is Chemomab Therapeutics Ltd. in?

    Chemomab Therapeutics Ltd. is in the Biotechnology industry

    What country is Chemomab Therapeutics Ltd. based in?

    Chemomab Therapeutics Ltd. is headquartered in Israel

    When did Chemomab Therapeutics Ltd. go public?

    Chemomab Therapeutics Ltd.'s initial public offering (IPO) was on February 12, 2019

    Is Chemomab Therapeutics Ltd. in the S&P 500?

    No, Chemomab Therapeutics Ltd. is not included in the S&P 500 index

    Is Chemomab Therapeutics Ltd. in the NASDAQ 100?

    No, Chemomab Therapeutics Ltd. is not included in the NASDAQ 100 index

    Is Chemomab Therapeutics Ltd. in the Dow Jones?

    No, Chemomab Therapeutics Ltd. is not included in the Dow Jones index

    When was Chemomab Therapeutics Ltd.'s last earnings report?

    Chemomab Therapeutics Ltd.'s most recent earnings report was on November 10, 2022

    When does Chemomab Therapeutics Ltd. report earnings?

    The date for Chemomab Therapeutics Ltd.'s next earnings report has not been announced yet
    On this page